Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",22161,176,1.46 [1.17-1.83],0.0009907890390988
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23178,186,0.92 [0.75-1.14],0.4704533250774889
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",22935,1384,1.16 [1.07-1.26],0.0002065024312685
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Candidiasis,23189,365,1.41 [1.21-1.65],1.3618479092674796e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,22508,3396,1.17 [1.11-1.23],3.287741186280666e-09
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),22469,3415,1.25 [1.19-1.32],1.3022290679931798e-17
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,22980,1025,1.17 [1.07-1.29],0.0009571117838023
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23113,79,1.01 [0.72-1.40],0.9647413676296442
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,21013,1098,1.28 [1.17-1.41],1.0272677823919881e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,20269,1212,1.36 [1.25-1.48],2.6566013275098515e-12
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,19998,243,1.78 [1.48-2.15],1.106482874115967e-09
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,16319,2226,1.24 [1.17-1.33],2.086506564898464e-11
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,19935,397,1.39 [1.19-1.61],2.742864041761377e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23178,1223,1.18 [1.08-1.28],0.0002196905379441
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Mycoses,23278,454,1.42 [1.24-1.64],7.312792997050695e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22434,883,1.18 [1.06-1.30],0.0014937237227426
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23200,1215,1.27 [1.16-1.38],6.175098695723717e-08
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22143,188,0.91 [0.74-1.13],0.4119341792503105
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23316,51,0.97 [0.65-1.47],0.8994570151572616
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23045,1060,1.26 [1.15-1.38],1.1124039105812426e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23103,69,0.96 [0.67-1.37],0.8063208870798163
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23258,118,1.25 [0.94-1.64],0.1195579150441311
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23240,100,1.20 [0.89-1.62],0.2408290845503086
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22027,476,1.33 [1.16-1.53],4.921168778211823e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,21835,284,1.16 [0.97-1.39],0.0997560746987057
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,22042,87,1.68 [1.24-2.28],0.000918168115033
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23297,67,1.43 [0.99-2.06],0.0560479953474485
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23262,137,0.85 [0.67-1.09],0.192436740732853
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Viral warts,23176,51,1.04 [0.68-1.58],0.8532731510379582
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23171,46,0.72 [0.49-1.03],0.075420869901073
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign lipomatous neoplasm,23011,339,0.94 [0.80-1.11],0.4694602999038862
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23247,45,0.80 [0.52-1.21],0.2917351656334011
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23217,53,0.96 [0.64-1.45],0.8544228779867227
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,23268,129,0.82 [0.64-1.05],0.1177783414642435
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",22947,1610,1.00 [0.93-1.08],0.9921988987016735
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm of meninges,23317,31,1.35 [0.80-2.28],0.2560880917918099
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23256,65,1.46 [1.01-2.11],0.0435997092839919
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23301,74,1.23 [0.87-1.74],0.2510299457152659
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23292,436,0.90 [0.78-1.04],0.1484905827452236
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm: Caecum,23286,334,1.07 [0.91-1.26],0.4199745538619759
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23188,79,0.98 [0.70-1.37],0.9121502441786712
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm: Descending colon,23286,270,0.96 [0.80-1.15],0.6665686340667631
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm: Rectum,23247,412,0.98 [0.84-1.13],0.7518797438610758
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23195,711,1.03 [0.92-1.15],0.6084783332609467
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23273,547,1.04 [0.92-1.18],0.5301376871818213
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",18124,68,1.08 [0.75-1.57],0.6644737040487699
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",18125,69,1.45 [1.00-2.09],0.0487433297302068
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23285,97,0.89 [0.66-1.20],0.4421690211908256
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Haemangioma, any site",23285,94,0.86 [0.64-1.15],0.3034953931493601
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Lung cancer and mesothelioma,15531,340,1.24 [1.05-1.47],0.0101114125457631
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Lymphoid leukaemia,18119,63,1.08 [0.74-1.58],0.6893218663374723
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",18250,194,0.97 [0.78-1.21],0.8071923502314067
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",18340,284,1.07 [0.90-1.28],0.451850914789163
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",18143,87,1.49 [1.08-2.07],0.0162687031044363
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",18198,142,1.13 [0.88-1.46],0.332638176200461
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",18193,137,1.10 [0.85-1.42],0.4845532914430875
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",18133,77,0.96 [0.68-1.34],0.7989133813601418
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",19412,1356,0.99 [0.91-1.07],0.782771029063297
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",18199,143,0.98 [0.77-1.26],0.8846932396583099
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",18159,103,1.05 [0.78-1.41],0.7376774790316358
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,18183,127,1.06 [0.81-1.39],0.6513819541085735
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Melanocytic naevi,23190,168,1.12 [0.89-1.41],0.3526109192083074
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Melanocytic naevi of trunk,23283,93,1.13 [0.83-1.54],0.4479141457861746
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Melanoma in situ,18088,71,0.91 [0.64-1.30],0.6149546903507072
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",18153,97,1.40 [1.03-1.91],0.0316708788512982
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",18216,160,1.41 [1.11-1.79],0.0055027710725131
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",18272,216,1.15 [0.94-1.41],0.1807973712317025
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",18156,100,1.27 [0.93-1.72],0.1292773791760688
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Other benign neoplasms of skin,23188,137,1.26 [0.98-1.63],0.0709469652665271
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",19239,1183,1.09 [1.00-1.19],0.0616680574423203
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",19314,1258,1.08 [0.99-1.18],0.0712601811944676
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23042,298,1.43 [1.21-1.70],3.679821644906438e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,21628,113,2.03 [1.57-2.64],9.023985698007849e-08
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,22815,71,1.52 [1.07-2.16],0.0180886133374527
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,22769,2707,1.24 [1.17-1.31],7.726683985025487e-13
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,22063,61,1.70 [1.17-2.45],0.0047850859198275
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,22906,53,1.33 [0.88-2.01],0.1760471884735548
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22944,1429,1.24 [1.15-1.35],6.692840628926689e-08
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22942,1427,1.24 [1.15-1.34],9.947474408902826e-08
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,21616,101,1.50 [1.11-2.02],0.0078278640811129
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23080,1078,1.23 [1.12-1.35],1.0418871696069067e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,22954,101,1.10 [0.81-1.48],0.5446492600251462
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,22819,75,1.54 [1.09-2.16],0.0141044225301582
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,22804,60,1.02 [0.70-1.50],0.9051237088084456
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23158,305,1.48 [1.25-1.76],5.019152223387769e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23223,46,1.59 [1.04-2.44],0.0330622147553161
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23100,247,1.52 [1.26-1.84],1.0977165825071604e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,22077,75,1.15 [0.81-1.62],0.4303385021754857
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,17200,363,1.40 [1.19-1.63],2.955420518298959e-05
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,21316,162,1.33 [1.05-1.69],0.017989658248803
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,21340,186,1.44 [1.16-1.80],0.0011076101124843
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,16892,55,1.21 [0.81-1.81],0.3529614704154588
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,21963,64,1.05 [0.72-1.53],0.7987915500899433
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21207,223,1.32 [1.08-1.61],0.0061231182211475
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",22823,607,1.32 [1.17-1.49],8.819708241859772e-06
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,22453,237,1.00 [0.82-1.21],0.9611309589358938
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,22379,163,1.09 [0.86-1.38],0.468542368606482
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23017,1118,1.05 [0.96-1.15],0.2444455070234848
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,19938,1074,1.09 [1.00-1.20],0.0532889212958804
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",16909,72,1.37 [0.96-1.95],0.0825792349825165
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",22452,39,2.29 [1.61-3.26],3.5629910780548992e-06
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,17104,267,1.49 [1.25-1.79],1.493514509421053e-05
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,16908,71,1.15 [0.80-1.64],0.4551375383080264
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,20620,3783,0.96 [0.92-1.01],0.1460813922641606
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,17022,185,1.27 [1.02-1.59],0.0330867695047973
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,17393,556,1.34 [1.18-1.52],6.6386686227928e-06
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23259,272,1.32 [1.10-1.58],0.0029934996608376
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23077,90,1.66 [1.23-2.24],0.000853513126093
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,16986,149,1.39 [1.08-1.78],0.0093747587380495
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",16903,66,1.26 [0.87-1.82],0.2214536857482005
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,23142,729,1.19 [1.07-1.33],0.0016708802474081
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,17137,300,1.60 [1.35-1.90],6.903782025816032e-08
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,17208,371,1.66 [1.43-1.93],4.557491080885201e-11
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",17553,716,1.02 [0.91-1.14],0.7569378305109435
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,16979,142,1.02 [0.79-1.31],0.896670398169283
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23070,83,1.67 [1.23-2.28],0.0010895923720994
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,17397,560,1.34 [1.18-1.52],7.177566380805619e-06
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,17222,385,1.20 [1.03-1.40],0.0196504825429483
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21053,69,1.51 [1.06-2.15],0.0228463647182743
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,21902,5065,1.03 [0.99-1.08],0.1149431044751742
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,22432,19,0.89 [0.46-1.73],0.7280449894305232
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,22435,22,0.91 [0.48-1.70],0.7591466504843748
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23148,1751,1.01 [0.94-1.08],0.8100808489464972
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23145,1747,1.01 [0.94-1.09],0.786000413510297
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,22435,22,1.17 [0.63-2.20],0.6207280593791349
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23047,790,0.99 [0.89-1.10],0.8759542024905806
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",18419,1582,1.33 [1.23-1.43],8.459838921656898e-14
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23305,260,2.00 [1.68-2.38],3.5006174551272832e-15
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,22323,107,1.36 [1.01-1.82],0.0398051625280648
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,22332,75,1.18 [0.84-1.66],0.3494257985394239
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,22339,82,1.18 [0.85-1.64],0.3276975519804325
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",16901,64,1.02 [0.70-1.49],0.9068653551236444
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,20590,163,1.83 [1.47-2.29],6.254394843787588e-08
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2444,122,1.94 [1.48-2.54],1.477308945648476e-06
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2601,309,1.43 [1.20-1.71],5.495714922190227e-05
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,20526,99,2.51 [1.94-3.24],2.984921117669595e-12
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2400,80,2.89 [2.13-3.91],7.48115716079078e-12
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,22537,2110,1.36 [1.28-1.46],3.296602620388513e-20
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,22570,354,1.11 [0.95-1.31],0.1827402079390487
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,21221,237,1.24 [1.02-1.50],0.0299013993726459
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,17617,780,1.20 [1.08-1.34],0.0007737694195235
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23200,247,1.26 [1.04-1.52],0.0188508717485047
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),22111,269,1.13 [0.94-1.35],0.1994001886890962
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Angina pectoris,20449,1465,1.07 [0.99-1.16],0.0835358674658508
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Aortic aneurysm,22218,376,1.14 [0.98-1.33],0.0910344128979844
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,21923,81,1.72 [1.25-2.37],0.0009457176386884
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",22083,241,1.53 [1.26-1.85],1.4399496358723307e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,13668,2269,1.15 [1.08-1.22],1.620792912248217e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,AV-block,18735,605,1.11 [0.99-1.26],0.0824503101127967
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23241,525,0.96 [0.84-1.09],0.5416478468895013
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Cardiac arrest,11649,250,1.25 [1.04-1.51],0.0191563896850831
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Cardiomyopathy,18328,198,1.19 [0.96-1.47],0.110251417812353
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",18239,109,1.39 [1.04-1.85],0.0270750874407434
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23317,66,1.17 [0.81-1.70],0.3988082982617358
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Conduction disorders,19467,1337,1.12 [1.03-1.21],0.0076531687873414
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,21548,2587,1.08 [1.02-1.15],0.0078897448476519
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,19622,7573,1.07 [1.03-1.11],0.0001196691370283
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22122,270,1.25 [1.04-1.50],0.0174020882760299
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Endocarditis,18216,86,0.99 [0.72-1.37],0.9658062956490924
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23008,1305,1.23 [1.13-1.34],9.077838118869646e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Hypertension,20803,6601,1.07 [1.03-1.11],0.0003046947362687
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Hypertension, essential",20828,6626,1.07 [1.03-1.11],0.0002657531648608
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23092,107,2.59 [2.11-3.18],8.794940660053546e-20
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",14385,183,1.45 [1.17-1.79],0.0005657841693482
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,14370,168,1.87 [1.53-2.28],1.18921877721716e-09
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Hypotension,23171,1212,1.22 [1.12-1.33],7.54118360513213e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,22260,115,1.04 [0.79-1.38],0.7691826981154839
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",21677,2693,1.07 [1.01-1.13],0.0203638502191633
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",22890,642,1.20 [1.06-1.34],0.0030902716584579
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Left bundle-branch block,18540,410,1.25 [1.08-1.45],0.0030119785087428
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,22599,1040,1.12 [1.02-1.22],0.020923899633755
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",19882,898,1.14 [1.03-1.26],0.0089001683994123
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23155,217,1.03 [0.84-1.26],0.7632544570651321
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23266,363,1.21 [1.04-1.42],0.0162712707736495
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Oesophageal varices,21917,65,2.33 [1.74-3.11],1.1381583490709898e-08
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other aneurysm,21937,95,1.19 [0.87-1.61],0.276550209481627
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other arrhythmias,18602,472,1.11 [0.97-1.28],0.1241610660555521
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,21972,130,1.48 [1.14-1.92],0.0033486283636369
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,22118,276,1.31 [1.09-1.57],0.0033819845960943
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,18318,188,0.95 [0.77-1.18],0.6697468709997418
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other disorders of veins,21946,94,1.14 [0.83-1.55],0.4233467034963717
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,21900,48,1.21 [0.79-1.87],0.3848256552293569
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,21747,90,0.99 [0.72-1.35],0.9400494026834048
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,21954,102,1.01 [0.75-1.36],0.94930027704397
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,19368,1238,1.12 [1.03-1.22],0.0085930198710416
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,22022,63,2.88 [2.24-3.69],8.189088124797523e-17
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,22410,568,1.24 [1.09-1.40],0.000794890193499
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,22684,361,1.52 [1.30-1.78],1.0350222962582677e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",22320,663,1.25 [1.11-1.40],0.0002179629235434
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,11768,369,1.28 [1.09-1.49],0.00186829222361
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Peripheral artery disease,22319,525,1.52 [1.33-1.73],2.374279354221819e-10
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22201,349,1.23 [1.05-1.44],0.0123867022210712
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Pulmonary embolism,22815,492,1.21 [1.06-1.39],0.0050779833534331
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23255,700,1.20 [1.07-1.34],0.0015444335986538
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Right bundle-branch block,18598,468,1.17 [1.02-1.34],0.0251262771612797
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Secondary right heart disease,22682,359,1.52 [1.30-1.77],1.5566678423662164e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,21875,218,1.32 [1.08-1.62],0.0071693059915148
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",22874,729,1.17 [1.04-1.30],0.0063359527361717
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",22860,758,1.18 [1.06-1.31],0.0032648209481078
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,22240,47,1.16 [0.75-1.80],0.4958057292462048
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,21955,114,1.26 [0.95-1.67],0.110954976846253
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Transient ischemic attack,22492,244,1.10 [0.91-1.33],0.3328978244652975
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,21873,314,1.10 [0.93-1.30],0.2848616285116679
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Varicose veins,22223,371,1.24 [1.06-1.45],0.0067602693690656
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,21858,69,1.35 [0.94-1.93],0.1040931692898751
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23090,771,1.21 [1.09-1.35],0.0005610355917711
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23123,491,1.24 [1.08-1.42],0.0019758304140164
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",20039,958,1.07 [0.97-1.17],0.2030582638877578
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,Any mental disorder,22643,3562,1.10 [1.05-1.16],0.0001185641529567
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23064,581,1.19 [1.05-1.35],0.0051927721927182
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",20234,1153,1.09 [1.00-1.19],0.0497543661272768
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19165,84,1.26 [0.90-1.75],0.1768324797526812
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,Smoking dependency,22686,1497,1.22 [1.13-1.32],4.028298881858935e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",20914,1833,1.18 [1.10-1.26],5.609704479220261e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,Vascular dementia,22816,150,1.01 [0.80-1.29],0.9230190977396874
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Alzheimer disease,23316,292,0.99 [0.83-1.18],0.9030029215955012
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",15483,58,1.13 [0.76-1.68],0.5537152621112339
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Bell's palsy,21981,75,1.16 [0.82-1.65],0.3948108843434054
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22241,335,0.93 [0.80-1.10],0.411483868252663
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Cerebral cysts,22926,233,1.22 [1.00-1.49],0.047788453128958
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23230,356,1.30 [1.11-1.52],0.001226427173008
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,22818,58,1.15 [0.77-1.69],0.495760563604683
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23296,73,1.17 [0.82-1.66],0.3789510363704658
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",22782,89,1.21 [0.88-1.66],0.2503923867414955
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Epilepsy,21731,278,1.11 [0.93-1.33],0.2556816477546136
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22785,1332,1.11 [1.02-1.21],0.0128572581233196
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23280,666,0.96 [0.86-1.08],0.5302945466329347
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Falls/tendency to fall,22782,2179,1.20 [1.12-1.28],4.0667567516569946e-08
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Generalized epilepsy,22938,57,1.17 [0.78-1.74],0.4506065470807092
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Hemiplegia,23146,272,1.30 [1.08-1.56],0.0046097478089692
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Hydrocephalus,22748,55,1.13 [0.75-1.69],0.5677276299234293
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23298,57,1.07 [0.72-1.60],0.7300385624038875
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,21926,20,1.08 [0.55-2.11],0.8172831682063837
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,21996,90,0.95 [0.69-1.29],0.7343157495279755
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Memory loss,22658,121,1.46 [1.11-1.90],0.0060017505792108
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Migraine,21646,193,1.06 [0.85-1.31],0.6183499317554781
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23292,175,1.07 [0.85-1.35],0.5450418772885851
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Motor neuron disease,15586,149,1.24 [0.97-1.58],0.0916788792576401
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23209,63,1.29 [0.89-1.88],0.176617955845378
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22856,950,1.03 [0.94-1.14],0.525419954825737
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Neurological diseases,22020,3592,1.10 [1.05-1.16],0.000179231855671
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,22995,235,1.34 [1.10-1.63],0.0033974866869126
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22288,382,1.08 [0.93-1.26],0.3229043199399204
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23225,343,1.55 [1.32-1.82],6.286712064738158e-08
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,18268,608,1.19 [1.05-1.34],0.0055100194058856
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,22768,75,1.38 [0.98-1.95],0.0675837923916346
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Other disorders of nervous system,22843,150,1.32 [1.03-1.68],0.0277940376876179
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,22748,134,1.12 [0.87-1.46],0.3794281752417916
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Other facial nerve disorders,21999,93,1.20 [0.88-1.64],0.2499693784394238
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Other headache syndromes,21488,35,0.75 [0.47-1.20],0.2317191791303769
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Other neurological diseases,23204,511,1.20 [1.05-1.37],0.0062644566696186
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Other sleep disorders,22139,686,1.11 [0.99-1.25],0.0740315563286092
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Parkinson's disease,23294,524,0.96 [0.84-1.09],0.4835590131671994
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,22720,27,1.08 [0.61-1.93],0.7938340790824783
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Restless leg syndrome,23316,48,1.12 [0.73-1.73],0.6033245557652458
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Sleep apnoea,23013,617,1.10 [0.98-1.25],0.1116117465773095
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Small fibre neuropathy,22936,54,1.25 [0.83-1.87],0.2823361174857672
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23300,174,1.24 [0.99-1.55],0.0642878175405788
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,21940,34,0.83 [0.52-1.34],0.4544990659182319
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23316,295,0.99 [0.84-1.18],0.93945045528671
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),22787,146,1.03 [0.81-1.31],0.812204220330218
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,22773,86,1.18 [0.86-1.63],0.3013226488233534
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,22981,292,0.96 [0.81-1.14],0.6621399357719151
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23120,287,1.82 [1.54-2.16],3.632310928516251e-12
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,22473,44,0.69 [0.45-1.05],0.0817664843876647
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22491,62,1.18 [0.80-1.73],0.3984942756304801
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23225,44,1.19 [0.75-1.87],0.4591066698141102
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23087,120,0.96 [0.74-1.26],0.7857258253667102
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2404,82,2.63 [1.94-3.57],4.820902963950126e-10
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2933,130,1.94 [1.49-2.52],6.567694532099594e-07
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,22782,95,1.20 [0.88-1.63],0.247520628055999
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23076,976,1.19 [1.08-1.31],0.0004757333583575
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23022,593,1.03 [0.91-1.16],0.6316327189204738
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22568,139,0.93 [0.73-1.19],0.5700636981569123
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23244,555,0.96 [0.85-1.09],0.5052478441306156
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23313,63,0.79 [0.55-1.12],0.1862220503183081
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23175,486,0.95 [0.84-1.09],0.4972490987327849
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23278,311,1.02 [0.86-1.20],0.8488018862992253
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23231,145,0.88 [0.69-1.12],0.2978475866271597
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,22506,77,1.03 [0.73-1.45],0.861711485220033
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,22510,81,1.01 [0.73-1.39],0.9755220606747512
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,22471,42,0.78 [0.51-1.18],0.2341198199817415
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23225,665,0.96 [0.86-1.08],0.5366838458994792
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,22738,178,1.00 [0.80-1.25],0.9969331777750836
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,22716,27,1.24 [0.70-2.21],0.4655762326126552
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23062,95,1.04 [0.77-1.42],0.7841326063592666
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23189,222,0.98 [0.80-1.20],0.8521411622755535
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,22853,164,0.94 [0.75-1.19],0.6096716231137262
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23168,82,0.82 [0.60-1.11],0.2000415641792272
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23012,452,0.99 [0.86-1.13],0.8334580669678017
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,22813,126,1.05 [0.81-1.37],0.7080113630690832
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,21978,1753,1.08 [1.00-1.16],0.0460362650284163
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23159,192,0.98 [0.79-1.22],0.867610398292705
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23300,142,1.14 [0.89-1.47],0.3009386667295875
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,22827,398,0.98 [0.85-1.14],0.8169008977364557
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23031,64,0.95 [0.66-1.38],0.7999348658148236
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23302,52,0.82 [0.55-1.21],0.3206320101760251
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,22500,71,0.74 [0.54-1.00],0.0519491631035236
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22557,128,0.99 [0.76-1.29],0.94734312224706
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,22222,122,1.23 [0.94-1.61],0.1301752200152346
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,22739,50,0.89 [0.59-1.34],0.5643059371814261
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",22161,61,0.98 [0.67-1.44],0.9364859020207849
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,22612,52,1.01 [0.67-1.53],0.9535280037712895
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",22762,202,0.92 [0.75-1.13],0.4091312082977961
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,22544,115,0.99 [0.75-1.31],0.9506227879084694
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,22219,119,0.89 [0.68-1.17],0.4102831478353088
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,22191,91,0.85 [0.63-1.15],0.3005909904608642
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,21658,1433,1.02 [0.94-1.10],0.6678384139065285
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,22484,55,0.83 [0.57-1.22],0.3381415758231594
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23075,388,1.11 [0.96-1.30],0.1658186573841257
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,22757,70,1.19 [0.83-1.70],0.3444466306481809
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),22853,166,1.37 [1.09-1.73],0.0074073126372137
SLAMF1,Signaling lymphocytic activation molecule,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23145,54,1.24 [0.83-1.88],0.2955656723808152
SLAMF1,Signaling lymphocytic activation molecule,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23274,119,0.99 [0.75-1.30],0.9377202825758384
SLAMF1,Signaling lymphocytic activation molecule,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23189,107,0.87 [0.66-1.16],0.344828965748887
SLAMF1,Signaling lymphocytic activation molecule,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23139,48,1.34 [0.88-2.06],0.1724009153665119
SLAMF1,Signaling lymphocytic activation molecule,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,23143,52,0.83 [0.56-1.24],0.366948861947122
SLAMF1,Signaling lymphocytic activation molecule,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23222,942,1.12 [1.01-1.23],0.0261321498178123
SLAMF1,Signaling lymphocytic activation molecule,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,22981,701,1.13 [1.01-1.27],0.0324027748869818
SLAMF1,Signaling lymphocytic activation molecule,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,22402,122,1.15 [0.88-1.51],0.3002612246569914
SLAMF1,Signaling lymphocytic activation molecule,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,22365,85,1.11 [0.80-1.53],0.5418539050903299
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Acute pharyngitis,23109,62,1.38 [0.95-2.01],0.0868670552682813
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23233,186,1.47 [1.19-1.82],0.0004237973132117
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23108,61,1.49 [1.02-2.18],0.0378512593136846
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,All influenza,21077,105,1.95 [1.48-2.58],2.040666459175135e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),21074,102,2.03 [1.54-2.67],4.891772334151245e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Allergic asthma (mode),15291,100,1.00 [0.74-1.34],0.978500394041998
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Allergic rhinitis,23210,258,0.96 [0.80-1.16],0.6823430481589259
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",16250,1402,1.12 [1.04-1.22],0.0043733587571619
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",16568,1377,1.13 [1.05-1.23],0.0024814753941344
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),22938,146,1.32 [1.03-1.68],0.0283674208096277
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",21066,94,1.22 [0.89-1.66],0.2171309346660543
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Bronchiectasis,20276,279,1.33 [1.11-1.59],0.0017600903022682
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",20037,40,1.21 [0.76-1.94],0.4287148980353115
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22486,2489,1.17 [1.10-1.24],3.4449084047855626e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",21907,77,0.90 [0.65-1.25],0.5330984959584195
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Chronic sinusitis,21985,155,0.88 [0.70-1.11],0.2764374109610729
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23095,1273,1.27 [1.16-1.37],2.6297748980647452e-08
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Deviated nasal septum,21965,135,0.99 [0.76-1.27],0.918576549829978
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,21341,5154,1.16 [1.12-1.21],1.5533071711874797e-12
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22210,380,1.12 [0.96-1.30],0.1517366319218131
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Early onset COPD,22121,299,1.24 [1.04-1.48],0.0143136067199169
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Emphysema,20335,338,1.44 [1.23-1.69],6.145942346755079e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22413,330,1.73 [1.48-2.03],6.3746688847750575e-12
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23073,2101,1.28 [1.20-1.37],9.41509337273378e-14
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Interstitial lung disease,22441,358,1.74 [1.49-2.02],6.845257892219725e-13
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Later onset COPD,22272,974,1.27 [1.15-1.39],8.592708359858376e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23299,424,1.23 [1.06-1.42],0.0056425998989927
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Nasal polyp,21969,139,0.82 [0.64-1.04],0.1055905558830997
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23048,979,1.41 [1.28-1.55],1.4692849323538477e-12
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Other diseases of pleura,23042,2143,1.26 [1.18-1.34],7.0763117480511156e-12
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22668,838,1.00 [0.90-1.10],0.9431936180992908
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Other pleural conditions,20963,64,1.15 [0.79-1.68],0.4613776814384973
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23223,437,1.67 [1.45-1.92],3.888715424014106e-13
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23197,1359,1.29 [1.19-1.40],1.1246371372780752e-09
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Pleural effusion,21995,1096,1.24 [1.13-1.35],5.47935994556389e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Pleural plaque,21157,258,1.32 [1.09-1.59],0.0043845560259142
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",22816,1844,1.30 [1.21-1.40],1.5282984410640973e-13
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23199,324,1.26 [1.07-1.49],0.0068860437778214
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Pneumothorax,21039,140,1.20 [0.93-1.54],0.1662298468915496
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Pollen allergy,23301,225,0.94 [0.77-1.14],0.5247328845842022
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Pulmonary oedema,22851,65,1.84 [1.29-2.62],0.0008004654025084
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Respiratory insufficiency,15245,54,1.55 [1.02-2.34],0.0386829321947866
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23034,965,1.43 [1.30-1.58],1.9141129076430733e-13
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22090,260,0.97 [0.81-1.16],0.7255394251569539
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Viral pneumonia,21249,277,1.21 [1.01-1.46],0.0381701905791711
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",22953,236,1.20 [0.98-1.46],0.071528003238862
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,10157,112,1.20 [0.90-1.59],0.2115260631398038
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,16292,86,1.14 [0.82-1.57],0.4360937283197974
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Acute appendicitis,23182,144,0.88 [0.69-1.12],0.2818241084250789
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Acute gastritis,17596,87,1.28 [0.93-1.76],0.1360946533166648
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Acute pancreatitis,21996,201,1.33 [1.08-1.65],0.007262874614225
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Acute peritonitis,22968,97,1.38 [1.02-1.87],0.0358790166215682
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Alcoholic liver disease,22449,112,2.47 [2.03-3.01],2.129009933339304e-19
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Barrett oesophagus,18033,524,1.12 [0.98-1.28],0.0845168368247218
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",21913,118,0.97 [0.74-1.27],0.8268937622356018
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",22922,118,0.96 [0.73-1.26],0.7589617071204322
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Cholecystitis,22008,213,1.13 [0.92-1.39],0.2397333269808079
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Cholelithiasis,22564,769,1.36 [1.22-1.51],2.4999661998011144e-08
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Chronic gastritis,17773,264,1.31 [1.09-1.58],0.0040962296510183
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Chronic pancreatitis,21852,57,1.38 [0.93-2.05],0.1078787871375866
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23116,131,2.79 [2.32-3.35],3.162628339637037e-28
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Coeliac disease,21724,91,1.88 [1.44-2.43],2.391435757171528e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Collagenous colitis,21922,49,0.72 [0.49-1.04],0.0821987587580131
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23152,213,1.14 [0.93-1.40],0.2086549136743587
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Constipation,23158,1548,1.15 [1.07-1.24],0.0003279349609751
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Crohn disease,21961,88,1.65 [1.23-2.21],0.0008972401460341
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",22982,64,1.57 [1.09-2.24],0.0142664305161799
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Crohn's disease NAS,21948,75,1.72 [1.26-2.35],0.0007020489449178
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Dental caries,22690,223,1.14 [0.93-1.39],0.2059308917382186
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,19739,1923,1.01 [0.94-1.08],0.7903187579530166
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diseases of appendix,23213,175,0.85 [0.69-1.06],0.1512103363801622
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diseases of liver,23179,842,1.54 [1.39-1.70],1.187371890641968e-16
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",21352,3843,1.08 [1.03-1.13],0.0018953196590748
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",22973,506,1.15 [1.01-1.32],0.0349073785291326
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23269,398,1.29 [1.11-1.50],0.0008444959453462
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22579,112,1.15 [0.87-1.53],0.3253991080958343
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diseases of salivary glands,22435,65,0.98 [0.68-1.43],0.9297335071569182
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23003,1370,1.16 [1.07-1.26],0.0003293690988436
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diseases of tongue,22456,106,1.61 [1.22-2.12],0.0007443087436636
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22960,1165,1.28 [1.17-1.39],5.823467802645978e-08
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,19189,2983,1.05 [0.99-1.11],0.0867120960747245
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Duodenal ulcer,17776,267,1.17 [0.97-1.40],0.0967209953339848
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23201,210,1.13 [0.92-1.38],0.2578146921594486
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23245,44,1.18 [0.75-1.85],0.4803301796177585
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,22491,154,2.64 [2.23-3.12],3.9345089298474486e-29
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,16382,176,1.13 [0.90-1.42],0.2989684625015294
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Functional dyspepsia,17926,417,1.06 [0.91-1.22],0.4584106444863055
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Gastric ulcer,17869,360,1.25 [1.07-1.47],0.005235815776503
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,19612,2103,1.04 [0.97-1.11],0.2695830893354401
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,18098,589,1.19 [1.06-1.35],0.0049268225773276
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,17818,7808,1.07 [1.04-1.11],3.308356592283132e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,GI-bleeding,22770,1137,1.13 [1.03-1.23],0.0085331375366214
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,22509,42,1.15 [0.72-1.84],0.5544364072746023
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,17151,1208,0.99 [0.90-1.07],0.735790036115928
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",22423,86,2.25 [1.75-2.88],2.1630174690809002e-10
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Hernia,21310,3494,1.02 [0.97-1.07],0.5579140358619001
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Impacted teeth,23248,41,1.14 [0.71-1.82],0.5896543494762452
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Impaction of intestines,16252,46,1.03 [0.67-1.59],0.8916297941628238
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Inguinal hernia,19428,1612,0.97 [0.90-1.05],0.4290517945368355
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",18009,193,0.86 [0.69-1.06],0.1520269516251419
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,16293,87,1.91 [1.45-2.51],3.433603232770798e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Intestinal malabsorption,21737,104,1.82 [1.42-2.34],2.2811799647801e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,16471,265,1.09 [0.91-1.31],0.3596558415407502
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23275,368,1.35 [1.16-1.58],0.0001662005188162
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22530,657,1.27 [1.13-1.42],7.628695404287487e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22734,861,1.24 [1.12-1.37],3.703913425307039e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Oesophageal obstruction,17722,213,1.07 [0.88-1.32],0.48873099239872
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Oesophagitis,18122,613,1.19 [1.05-1.34],0.0050075664278742
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23265,110,1.03 [0.77-1.36],0.8520975026311179
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,17892,76,0.87 [0.62-1.22],0.4210586001975368
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,17599,1393,1.02 [0.94-1.11],0.5868379484847888
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22049,254,1.01 [0.84-1.22],0.9188405123258622
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,21914,119,1.09 [0.83-1.43],0.5485948875123181
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of intestine,18040,1834,1.04 [0.97-1.11],0.2890686407549383
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of intestines,21536,5330,1.07 [1.03-1.12],0.0006038311883006
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22417,172,1.07 [0.85-1.35],0.543684671081754
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of liver,23007,670,1.51 [1.35-1.70],1.912569204860584e-12
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,18238,729,1.14 [1.02-1.28],0.0192000426096966
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of pancreas,21935,140,1.50 [1.17-1.93],0.0012866698971927
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23197,326,1.23 [1.04-1.46],0.0137561984675069
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,18290,781,1.27 [1.14-1.41],1.5620717757357025e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22782,1149,1.12 [1.03-1.23],0.0098920046940089
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22644,177,1.02 [0.82-1.28],0.850234780272459
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,17791,1585,1.17 [1.09-1.26],2.8739890361518942e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19334,1825,1.12 [1.05-1.20],0.0012601397414164
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,22430,93,1.60 [1.18-2.16],0.0025238442753796
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22627,754,1.24 [1.11-1.38],0.0001355193112795
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",16549,343,1.29 [1.09-1.51],0.0022082684212392
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23236,53,1.16 [0.77-1.75],0.486065469450081
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,16673,467,1.38 [1.20-1.58],4.015417543266307e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",21792,159,1.18 [0.93-1.50],0.1621243928496349
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23303,38,1.34 [0.82-2.17],0.240034220986584
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22476,100,1.70 [1.30-2.23],0.0001150410055305
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Toxic colitis,21917,44,1.33 [0.84-2.09],0.2231593290333337
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,17802,293,1.09 [0.91-1.29],0.3464839766771395
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Ulcerative colitis,22017,144,1.40 [1.10-1.78],0.0056876946702408
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",21995,122,1.43 [1.11-1.85],0.005389668914439
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Umbilical hernia,18179,363,1.10 [0.94-1.29],0.2319584594101762
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,16356,150,1.21 [0.94-1.54],0.133017833321323
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Ventral hernia,18075,259,1.33 [1.10-1.61],0.0026847677779665
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Volvulus,16279,73,1.24 [0.88-1.76],0.2245752942005248
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23241,323,1.13 [0.96-1.34],0.1368070608038443
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23005,66,0.90 [0.63-1.29],0.5761539017538108
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,21351,96,1.40 [1.04-1.90],0.0283229652201569
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22597,733,1.24 [1.10-1.38],0.0002131817258095
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22061,197,1.14 [0.92-1.41],0.2469606486482991
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,21720,465,1.28 [1.11-1.47],0.0005546753768432
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23032,265,1.17 [0.97-1.41],0.0921608981885283
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23230,463,1.25 [1.09-1.44],0.0016517769787576
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,22811,44,1.94 [1.36-2.77],0.0002496386490014
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,21869,3121,1.17 [1.11-1.23],1.7395067553210422e-08
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,22878,399,1.02 [0.88-1.18],0.8303835217550884
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,22768,289,1.01 [0.85-1.21],0.8889600966849809
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,22867,1003,1.20 [1.09-1.32],0.0001461351010245
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23306,31,0.74 [0.45-1.20],0.2231071074557076
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,21278,23,0.84 [0.47-1.53],0.5789332082326105
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22535,56,1.14 [0.76-1.69],0.5338432534001403
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23027,260,1.18 [0.98-1.42],0.0891261413655506
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,21727,472,1.19 [1.04-1.37],0.0128491931228706
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,21334,79,1.49 [1.07-2.08],0.0174533004230732
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23251,81,1.21 [0.87-1.69],0.2621233170093007
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,22077,213,1.37 [1.11-1.69],0.0028878512998345
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23149,210,0.95 [0.77-1.16],0.5891781601173626
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,22838,71,1.21 [0.84-1.73],0.2981383288693467
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,21323,68,1.09 [0.75-1.56],0.6553253597999974
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22871,1616,1.24 [1.15-1.33],2.6041776884174075e-08
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",21766,511,1.24 [1.08-1.41],0.0017772929233088
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,21337,82,1.47 [1.06-2.03],0.0209436306614222
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23230,291,0.90 [0.76-1.06],0.2150881395736058
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,22819,52,1.48 [0.98-2.23],0.0597909473359085
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23193,254,0.92 [0.76-1.10],0.3424462843877948
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23261,343,1.13 [0.96-1.32],0.148509671909517
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,21344,89,1.34 [0.98-1.84],0.0662596666115875
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,21522,267,1.02 [0.85-1.22],0.8409430246052066
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23254,336,1.15 [0.97-1.35],0.1023625917803235
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",21522,267,1.60 [1.33-1.92],4.215076626509133e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23293,123,1.47 [1.12-1.92],0.0049341557780938
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,20132,86,1.12 [0.81-1.55],0.5005522560231218
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,21283,4673,1.07 [1.02-1.11],0.0034802034155238
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,19893,3283,1.04 [0.98-1.09],0.1674737861672587
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,20113,67,0.88 [0.61-1.26],0.4807899348010473
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20470,148,1.07 [0.84-1.38],0.5713725355135026
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20463,141,1.23 [0.95-1.58],0.1175525910012942
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23121,68,1.25 [0.86-1.80],0.2373894264458097
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",20400,78,1.43 [1.02-2.01],0.0360429900822843
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,17456,846,1.02 [0.92-1.13],0.7343299465736659
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23202,144,0.95 [0.74-1.22],0.692882960518679
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,20589,267,1.24 [1.03-1.49],0.0235665841792207
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,19852,6126,1.07 [1.03-1.11],0.0003488124921032
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,22281,90,1.09 [0.80-1.50],0.5758924278866081
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,20210,164,1.21 [0.95-1.52],0.1160616908628433
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,20468,422,1.08 [0.93-1.25],0.3253341168067258
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22514,2192,1.08 [1.02-1.16],0.0124566498216816
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20398,352,1.15 [0.98-1.35],0.0779759195306847
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,20098,52,0.97 [0.64-1.46],0.8698119403541418
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20140,94,1.05 [0.77-1.42],0.7742239565171363
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,23004,29,0.61 [0.39-0.95],0.0308444705790058
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,18034,1424,1.02 [0.95-1.11],0.5479666439179878
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,17568,958,1.18 [1.07-1.30],0.0008455060575572
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23180,945,1.17 [1.06-1.29],0.0018114383310594
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,16658,48,0.62 [0.45-0.84],0.0024086198209426
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),16689,79,1.03 [0.73-1.43],0.8768069231666686
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20313,267,1.03 [0.86-1.24],0.7345401245606531
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,17226,616,0.96 [0.85-1.08],0.4691770865662836
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,20364,42,1.47 [0.93-2.33],0.0971325141591489
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,20841,519,1.02 [0.89-1.16],0.7989438154429269
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20582,260,1.01 [0.84-1.22],0.8791441501596987
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,17186,576,0.95 [0.84-1.08],0.4612993304476517
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,20109,63,1.19 [0.82-1.74],0.3630261966426721
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",20099,53,1.31 [0.87-1.98],0.1969437467306859
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,22285,94,1.45 [1.06-1.98],0.0189199646810026
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23036,845,1.23 [1.11-1.37],6.466940194271169e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22582,391,1.22 [1.05-1.42],0.0104406073058737
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23234,279,1.23 [1.03-1.47],0.0238264818797857
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18443,1833,1.08 [1.01-1.16],0.0343295233772823
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,16660,50,1.10 [0.72-1.68],0.6685003739998288
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,20128,82,0.85 [0.62-1.17],0.317641625652157
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,16660,50,1.63 [1.08-2.46],0.0196457435375682
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),16654,44,1.10 [0.70-1.73],0.6861350916180037
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,22372,181,1.43 [1.14-1.78],0.0016204188334076
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,22350,159,1.03 [0.81-1.30],0.8031272745681863
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23282,85,1.27 [0.92-1.75],0.1530810795902896
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",21814,1492,1.03 [0.96-1.12],0.3863342375385817
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20108,62,0.90 [0.62-1.31],0.5898107440229529
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),16650,40,0.91 [0.57-1.43],0.6723405241116085
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,20923,601,1.00 [0.88-1.13],0.9561618408297962
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,18295,1685,1.09 [1.01-1.17],0.0260446010415385
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,23028,53,0.72 [0.50-1.04],0.0815530637180704
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23299,61,0.93 [0.64-1.36],0.705455513372222
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20126,80,1.21 [0.87-1.70],0.2549903066541766
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21017,971,1.15 [1.04-1.26],0.0054747503626852
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,20139,93,1.15 [0.85-1.58],0.3661316313422148
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,17794,1184,1.01 [0.93-1.11],0.7384436273218873
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,22275,84,1.17 [0.84-1.62],0.3599313007702019
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,20089,43,1.28 [0.81-2.02],0.2967651910230198
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,20431,109,1.11 [0.83-1.48],0.4754396151174548
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20540,494,1.23 [1.07-1.40],0.0030433601543967
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23167,192,1.11 [0.90-1.38],0.3252342996905358
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,20791,469,1.10 [0.96-1.27],0.1669814225829444
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23243,274,1.25 [1.04-1.50],0.0163022004160665
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23301,37,1.77 [1.12-2.80],0.014104457550858
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20193,147,1.09 [0.85-1.40],0.494116789963
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,19122,565,1.23 [1.09-1.40],0.0012578774516352
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20518,472,1.10 [0.96-1.27],0.1585447444198866
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20365,319,1.12 [0.95-1.32],0.1818253379886789
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",16641,31,1.22 [0.71-2.08],0.4744487182978827
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,18832,2222,1.08 [1.01-1.15],0.0168172482572061
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,17052,442,1.05 [0.92-1.21],0.4653360949798112
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,23138,163,1.10 [0.87-1.39],0.428103153579965
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23244,47,1.09 [0.70-1.69],0.700149712644857
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",21380,45,0.91 [0.59-1.39],0.6557736376837051
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,16672,62,0.93 [0.64-1.36],0.720359851966496
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,20405,83,0.83 [0.60-1.14],0.2549209993651654
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,16897,287,1.24 [1.04-1.48],0.0165109657132513
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20320,274,1.00 [0.84-1.20],0.966357925242366
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20534,212,0.77 [0.63-0.93],0.0077437302289458
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,20413,91,1.49 [1.09-2.03],0.0119218187673383
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,18528,30,1.31 [0.77-2.22],0.3270429061826814
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23302,38,1.70 [1.07-2.69],0.0233345528474628
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20561,515,1.06 [0.93-1.21],0.4153716654656098
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],22993,18,1.47 [0.74-2.93],0.274856191205534
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22267,2221,1.10 [1.03-1.17],0.0051126155009777
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20147,101,1.47 [1.10-1.96],0.009544623000479
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,20821,499,1.12 [0.98-1.28],0.1070191879499365
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22282,190,1.03 [0.83-1.28],0.7638231871124951
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,20449,127,1.03 [0.79-1.34],0.8394869581253043
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21614,1292,1.12 [1.03-1.21],0.0097757830146048
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21132,810,1.09 [0.98-1.22],0.0965079839570396
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],20089,43,0.77 [0.50-1.19],0.2391549256683979
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23012,37,1.35 [0.83-2.18],0.2243429406679607
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20162,116,0.99 [0.75-1.30],0.9429984008687412
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,20069,23,2.07 [1.19-3.60],0.0104147432612497
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),16669,59,1.68 [1.17-2.41],0.0047211211878936
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Acute renal failure,22338,1831,1.43 [1.33-1.53],1.3121161800654996e-23
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,22844,392,1.07 [0.92-1.25],0.3796641817495345
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,22591,139,1.16 [0.90-1.49],0.2667805013649857
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,22015,1508,1.40 [1.30-1.52],1.4308312109966005e-17
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23065,83,2.30 [1.75-3.03],2.645111806311948e-09
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23039,350,1.17 [1.00-1.37],0.0557353529475946
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Cystitis,20498,209,1.11 [0.91-1.37],0.3031792188665067
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Dialysis,20612,105,2.43 [1.93-3.06],3.3609906600684245e-14
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,22062,3247,0.99 [0.94-1.04],0.5951196564659889
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,20987,5456,1.08 [1.04-1.13],8.975264540578439e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23083,101,2.27 [1.77-2.90],6.707090114780547e-11
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Hydrocele,19023,208,0.93 [0.76-1.14],0.4816044570007324
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,20610,359,1.24 [1.06-1.45],0.0088627045265388
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,21360,2545,1.01 [0.95-1.07],0.7171665876741997
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),19045,230,0.84 [0.70-1.01],0.0704854134285662
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,20367,78,1.18 [0.84-1.66],0.32986599919392
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,18924,109,0.89 [0.68-1.18],0.4164854912460674
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23305,60,1.13 [0.77-1.65],0.5419103264377961
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23308,57,1.05 [0.71-1.56],0.7949182110504727
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22500,2211,1.05 [0.99-1.12],0.1202341411722422
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,21222,933,0.98 [0.89-1.08],0.6253609384049158
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23240,551,1.24 [1.09-1.41],0.0011009278707477
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,19123,308,1.04 [0.88-1.23],0.6380314679119293
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,19095,280,0.93 [0.78-1.11],0.4374709046073868
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,19035,220,0.89 [0.74-1.08],0.2529427691940181
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23299,49,0.94 [0.62-1.42],0.7666044068157074
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,21798,1509,1.14 [1.05-1.23],0.0012691950719537
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,20654,403,1.17 [1.01-1.37],0.0382057430878147
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,22875,186,1.18 [0.95-1.47],0.1377227902183544
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,23041,59,1.37 [0.92-2.02],0.1183497645094339
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",19078,263,1.00 [0.83-1.19],0.9601581120779712
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23017,2766,1.29 [1.22-1.37],2.972811780691013e-18
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",20324,73,1.18 [0.82-1.68],0.3678946164473798
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,20662,155,1.80 [1.43-2.27],5.808293069730334e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,22529,77,1.36 [0.97-1.90],0.0738247741044899
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Urethral stricture,20577,288,1.04 [0.88-1.25],0.6304860168968647
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Urolithiasis,22962,510,1.10 [0.96-1.25],0.171354622506782
